CELCUITY INC. (CELC) Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..
Cash and securities
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 182.05M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $182.05M | (m) | (m) |
| 2026-03-31 | (m) | (m) | $145.19M | (m) | (m) |
| 2025-12-31 | (m) | (m) | $165.70M | (m) | (m) |
| 2025-09-30 | (m) | (m) | $74.25M | (m) | (m) |
| 2025-06-30 | (m) | (m) | $46.35M | (m) | (m) |
| 2025-03-31 | (m) | (m) | $16.48M | (m) | (m) |
| 2024-12-31 | (m) | (m) | $22.51M | (m) | (m) |
| 2024-09-30 | (m) | (m) | $12.60M | (m) | (m) |
| 2024-06-30 | (m) | (m) | $30.46M | (m) | (m) |
| 2024-03-31 | (m) | (m) | $31.21M | (m) | (m) |
| 2023-12-31 | (m) | (m) | $30.66M | (m) | (m) |
| 2023-09-30 | (m) | (m) | $25.76M | (m) | (m) |
| 2023-06-30 | (m) | (m) | $32.24M | (m) | (m) |
| 2023-03-31 | (m) | (m) | $33.64M | (m) | (m) |
| 2022-12-31 | (m) | (m) | $24.57M | (m) | (m) |
| 2022-09-30 | (m) | (m) | $57.48M | (m) | (m) |
| 2022-06-30 | (m) | (m) | $66.91M | (m) | (m) |
| 2022-03-31 | (m) | (m) | $78.30M | (m) | (m) |
| 2021-12-31 | (m) | (m) | $84.29M | (m) | (m) |
| 2021-09-30 | (m) | (m) | $90.37M | (m) | (m) |
| 2021-06-30 | (m) | (m) | $41.64M | (m) | (m) |
| 2021-03-31 | (m) | (m) | $34.94M | (m) | (m) |
| 2020-12-31 | (m) | (m) | $11.64M | (m) | (m) |
| 2020-09-30 | (m) | (m) | $13.70M | (m) | (m) |
| 2020-06-30 | (m) | (m) | $15.43M | (m) | (m) |
| 2020-03-31 | (m) | (m) | $16.85M | (m) | (m) |
| 2019-12-31 | (m) | (m) | $18.74M | (m) | (m) |
| 2019-09-30 | (m) | (m) | $16.27M | (m) | (m) |
| 2019-06-30 | (m) | (m) | $14.92M | (m) | (m) |
| 2019-03-31 | (m) | (m) | $14.72M | (m) | (m) |
| 2018-12-31 | (m) | (m) | $15.94M | (m) | (m) |
| 2018-09-30 | (m) | (m) | $3.81M | (m) | (m) |
| 2018-06-30 | (m) | (m) | $3.17M | (m) | (m) |
| 2018-03-31 | (m) | (m) | $2.57M | (m) | (m) |
| 2017-12-31 | (m) | (m) | $2.64M | (m) | (m) |
| 2017-09-30 | (m) | (m) | $32.30M | (m) | (m) |
| 2017-06-30 | (m) | (m) | $10.91M | (m) | (m) |
| 2017-03-31 | (m) | (m) | $4.90M | (m) | (m) |
| 2016-12-31 | (m) | (m) | $5.86M | (m) | (m) |
| 2016-09-30 | (m) | (m) | $6.57M | (m) | (m) |
| 2015-12-31 | (m) | (m) | $5.07M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |